According to a market report by Lucintel, the future of the global microbiome therapeutic market looks promising with opportunities in the c. difficile, Crohn's disease, and inflammatory bowel disease, and diabetes markets. The global microbiome therapeutic market is expected to reach an estimated $1 billion by 2030 with a CAGR of 32.4% from 2024 to 2030. The major drivers for this market are rising number of strategic collaborations for microbiome therapeutics for R&D and surge in the prevalence of target disease.
A more than 150–page report is developed to understand Trends,
opportunity and forecast in microbiome therapeutic market to 2030 by type (FMT
and microbiome drug), application (c. difficile, crohn’s disease, inflammatory
bowel disease, diabetes, and others), and region (North America, Europe, Asia
Pacific, and the Rest of the World).
In this market, FMT and microbiome drug are the major segments of
microbiome therapeutic market by type. Lucintel forecasts that FMT will remain
the larger segment over the forecast period due to rising R&D focusing on
developments to discover other therapeutic applications of FMT.
Within this market, c. difficile is expected to witness the highest
growth.
Download sample by clicking on microbiome
therapeutic market
North America will remain the largest region over the forecast period due
to growing target population in the region.
OpenBiome, Seres Therapeutics, Locus Biosciences, 4D Pharma, Enterome,
Finch Therapeutics, Intralytix, Microbiotica, Second Genome, and Rebiotix are
the major suppliers in the microbiome therapeutic market.
This unique research report will enable you to make confident business
decisions in this globally competitive marketplace. For a detailed table of
contents, contact Lucintel at +1-972-636-5056 or write us at helpdesk@lucintel.com
About Lucintel
At Lucintel, we offer solutions for you growth
through game
changer ideas and robust market & unmet
needs analysis. We are based in Dallas, TX and have
been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in
several publications like the Wall Street Journal, ZACKS, and the Financial
Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1 972.636.5056
Explore Our Latest
Publications
Epoxy
Adhesive Market in Canada
Expanded
Metal Fence Market in Canada
Flame
Retardant Pbt Market in Canada
No comments:
Post a Comment